paclitaxel-PCat-siRNAsurvivin (Optimum Therapeutics)

N/A

Report date: 2025/03/20 09:40:21
NME

Base Information

Drug Namepaclitaxel-PCat-siRNAsurvivin (Optimum Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Small Interfering RNA
Mechanisms of ActionBaculoviral IAP repeat-containing protein 5 inhibitors
TargetsBaculoviral IAP repeat-containing protein 5
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOptimum Therapeutics Llc
China Registration ClassN/A

Develop Information

Active CompaniesOptimum Therapeutics Llc
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A